Understanding Medications and Therapeutics

Explore cellular receptor pharmacology through loperamide, a poorly absorbed opioid for diarrhoea, and compare endogenous and exogenous opioids, bindings, receptor types, and safety considerations.

Develop safe diarrhea management by prioritizing oral rehydration and fluids, recognizing dehydration risk factors, electrolyte and acid-base disturbances, and signs like dry mouth and decreased skin turgor.

Learn how medications are named, distinguishing brand names from the generic name. The generic name, an abbreviated form of the chemical name, is the most important to remember, e.g., Harmonium.

Learn to identify medications by their generic names and key suffixes, recognizing beta blockers like propranolol, benzodiazepines such as lorazepam, and corticosteroids among the top prescribed drugs.

Understand how endogenous opioids act as inhibitory neurotransmitters to dampen pain along the spinal cord to the brain, and compare them with opioid analgesics and the diarrhea drug low pyramid.

Develop clinical reasoning and safety strategies to understand opioid effects, from euphoria and pain relief to respiratory depression and severe constipation, including loperamide overdose risks and cardiac toxicity.

Explore cellular receptors, their four types, and how ligand binding triggers conformational changes and cascades. See how insulin and other ligands influence surface and intracellular receptors to regulate protein production.

Explain how opioid receptors downregulate with pharmacologic doses, causing rebound pain as pain signaling returns stronger when opioids are used beyond recommended durations.

Explore how medications bind to receptors, examining affinity, selectivity, and potency, and how binding forces like ionic bonding and hydrogen bonds shape therapeutic effects.

Understand how cellular receptors receive signals, how medications bind or mimic natural ligands, and how upregulating or downregulating receptors alters pain perception and rebound effects.

Understand how agonists activate cellular receptors like ligand-gated ion channels, while antagonists block them, with partial and inverse agonists shaping constitutive activity and responses.

Explore how agonists, antagonists, and partial agonists regulate receptor activity, with scenarios showing how a low-activity partial agonist can behave like an antagonist and examples like buprenorphine in opioid withdrawal.

Opioids bind to enteric nervous system receptors, slowing peristalsis and increasing fluid absorption to dry the feces. Locally acting opioids stay in the gut to relieve diarrhea.

Identify presenting complaints and dehydration risks before OTC treatment; learn generic names, understand loperamide’s receptor actions, and preview pharmacokinetics—absorption, distribution, metabolism, and excretion.

Explore pharmacodynamics and pharmacokinetics, including receptor agonists and antagonists, histamine-2 blockers, and the four processes—absorption, distribution, metabolism, excretion.

Explore pharmacokinetics by examining how drugs are absorbed, distributed, metabolized, and excreted. Learn why pharmacokinetics describes what the body does to the drug.

Compare absorption of medications across routes such as oral, inhaled, subcutaneous, and intravenous, and see how each method influences absorption time and the C Max.

Compare oral vs intravenous or inhaled drugs, noting higher c-max and overdose risk with systemic routes; explain rapid first-half-life metabolism shaping absorption.

Explore how oral medications absorb mainly in the small intestine, with limited stomach absorption. Consider how molecular size, acidity or alkalinity, and lipophilicity influence diffusion and bioavailability.

Learn how absorption rate varies by administration method; lipophilic drugs absorb best, water-soluble drugs poorly. Rely on lipophilicity for deeper access in transdermal patches and sublingual sprays.

Understand drug distribution after absorption, including hepatic first-pass metabolism and protein binding to albumin or globulins, and how unbound fractions and equilibrium across compartments drive action.

Understand how drugs bind to albumin or globulin, with only the unbound portion acting, and how drug B displaces drug A from binding sites, increasing toxicity risk via liver metabolism.

Explore drug metabolism in the liver, including first-pass effects, cytochrome P450–mediated phase 1 and phase 2 reactions, and prodrugs like codeine, to explain bioavailability and excretion.

Explore how the liver metabolizes prodrugs into active metabolites using aspirin as an example. Assess why topical administration may fail due to absorption and first-pass metabolism.

Explore excretion in pharmacokinetics, focusing on drug half-life and how first-order and zero-order kinetics govern elimination. Learn why alcohol follows zero-order kinetics and how enzyme induction affects metabolism.

Understand how the half-life governs medication levels through a four-milligram, four-hour example, showing non-linear decay and the need to reset the timer within pharmacokinetics (absorption, distribution, metabolism, excretion).

Explore histamine 2 receptor blockers, such as ranitidine and famotidine, their -tidine suffix, and how they reduce stomach acid; distinguish them from antacids and identify 22 of the 200 meds.

Identify and understand key drug classes among the 200 most prescribed medications, including h2 antagonists, ace inhibitors, arbs, beta blockers, and statins, learn their impact on the renin-angiotensin system.

Explore histamine 2 receptor blockers like Ranitidine that reduce stomach acidity for peptic ulcers and gastro-oesophageal reflux disease, and examine how acid suppression affects drug absorption and potential side effects.

Predict side effects of histamine H2 receptor blockers by analyzing their impact on acid-dependent nutrient absorption, infection risk, and drug interactions, with emphasis on calcium, magnesium, and vitamin B12.

Compare histamine H2 blockers with proton pump inhibitors, noting PPIs reduce acid about 99 percent. Explain that H2 blockers are competitive antagonists at parietal H2 receptors with limited H1 crossover.

Differentiate histamine 1 and histamine 2 receptors: antihistamines (H1 blockers) treat allergies such as allergic rhinitis, while H2 blockers reduce stomach acid by blocking parietal cell receptors.

We explore histamine two blockers and build a pharmacokinetics foundation. We learn seven suffixes to identify drug classes, compare histamine two blockers with antihistamines, and preview proton pump inhibitors.

Explore enzymatic inhibitors with a focus on proton pump inhibitors, distinguish reversible and irreversible types, and examine safety issues and pharmacokinetics.

Explore how reversible and irreversible enzymatic inhibitors affect duration, and how cells replace inhibited enzymes by transcribing DNA in the nucleus and synthesizing new proteins.

Explore pharmacokinetics by tracing an oral drug from intestinal absorption to hepatic first-pass metabolism by cytochrome P450 enzymes. Understand distribution, protein binding, and excretion, and grasp bioavailability.

Explore how hepatic metabolism and bile canaliculi shape drug bioavailability, with 60% absorption and 40% excreted. Understand why an irreversible H+/K+ ATPase inhibitor lasts longer than its 1 hour half-life.

Explore how enzymes catalyze bodily reactions and how medications inhibit enzymatic activity via reversible and irreversible mechanisms, including competitive and noncompetitive inhibitors at active or allosteric sites.

Explore how aspirin irreversibly inhibits cyclooxygenase in platelets for the nine days and why platelets cannot replace the enzyme, unlike other cells that can degrade drugs and synthesize new enzymes.

Proton pump inhibitors irreversibly inhibit the hydrogen potassium ATPase pump in parietal cells, dramatically reducing stomach acid and providing a long-term approach to acid suppression.

Explain how the hydrogen potassium pump, an enzyme in parietal cells, uses ATP to ADP to drive hydrogen into the stomach lumen and is inhibited by proton pump inhibitors.

Explore how enzymatic inhibitors like NSAIDs and proton pump inhibitors block cox enzymes, risking ulcers and kidney damage, and alter metabolism via CYP2C19 and CYP3A4.

Explore how grapefruit juice inhibits CYP3A4, altering prodrug activation and active drug levels, and how enzyme induction, including ethanol, changes metabolism.

Explore proton pump inhibitors like omeprazole, their uses for GERD and peptic ulcers, and safety considerations across pregnancy categories; understand risks, interactions, and long-acting acid suppression.

Identify major drug suffixes such as -statin, -sartan, -pril, -olol, -tidine, pred, -olam, -prazole, and -vir to recognize 42 of the top 200 prescribed medications.

Review pharmacokinetics and pharmacodynamics, including reversible and irreversible enzymatic inhibitors, with competitive and non-competitive types, and examine drug interactions via cytochrome P450, pregnancy categories, and proton pump inhibitors.

Develops an overview of neurotransmission and drugs that affect neurons, links vomiting to brainstem control and neurotransmitters, and outlines safety, anatomy, physiology, and non-neurotransmitter treatments.

Most antiemetics work by blocking neurotransmitters in neurons. A direct GI tract acting option, bismuth subsalicylate, provides local anti-inflammatory, acid-reducing, and antibacterial effects to soothe mild gastric irritation.

Explore how neurons communicate via neurotransmitter release and receptor binding, and how drugs act as antagonists, agonists, or by inhibiting neurotransmitter degradation or reuptake.

Explore how antidepressants increase serotonin and noradrenaline in mood-related brain regions by inhibiting degradation or reuptake, including monoamine oxidase inhibitors and selective serotonin reuptake inhibitors, and weigh safety and benefits.

Assess safety in vomiting by noting fluid and electrolyte loss, dehydration, and metabolic alkalosis, while considering non-digestive causes and chemoreceptor trigger zone signaling to the vomiting center.

Identify safety concerns in pediatric vomiting, recognize signs of type 1 diabetes with fruity breath and ketones, and explore the four vomiting center pathways and appropriate medications.

this lecture outlines four vomiting pathways and shows how benzodiazepines treat higher brain vomiting, while motion sickness responds to antihistamines and anticholinergic agents like scopolamine, including key side effects.

Block histamine 1 and acetylcholine to treat motion sickness by crossing the blood-brain barrier, then assign loratadine for Joel and scopolamine for Alma and Yvonne.

Block serotonin 3 and dopamine 2 pathways to prevent vomiting, using 5-HT3 antagonists such as ondansetron for chemotherapy-induced emesis and D2 antagonists like prochlorperazine and metoclopramide, noting side effects.

Explain chemotherapy-induced vomiting and how antiemetics target vomiting center and chemo receptor trigger zone, compare bismuth subsalicylate, antihistamines, scopolamine, lorazepam, metoclopramide, and ondansetron, and identify ondansetron as most effective option.

gain a strong pharmacology foundation by linking safety issues, anatomy and physiology, and neuron-targeting medications within a contextual framework. apply this approach to drug knowledge beyond memorization for real-world use.